Suppr超能文献

对完全化学稳定的小干扰RNA中七种主链和核糖修饰的位点特异性耐受性的系统评估

Systematic Evaluation of Position-Specific Tolerability of Seven Backbone and Ribose Modifications in Fully Chemically Stabilized siRNAs.

作者信息

O'Reilly Daniel, Furgal Raymond, Hariharan Vignesh, Lochmann Clemens, Cooper David, Echeverria Dimas, Khvorova Anastasia

机构信息

RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

出版信息

Nucleic Acid Ther. 2025 Jun;35(3):137-149. doi: 10.1089/nat.2024.0077. Epub 2025 May 26.

Abstract

Chemically modified short interfering RNAs (siRNAs) unequivocally represent a groundbreaking class of drugs. The deliberate chemical modification of the natural structure has been pivotal to their resounding success. Specific modifications at certain positions bolster their potency, safety, stability, and specificity. In clinical research, 2'--methyl and 2'-fluoro are the most used modifications. The effects of a wide range of chemical changes in fully modified siRNAs have not been thoroughly evaluated for tolerability. In this study, we utilized two sequences in a fully modified siRNA to systematically assess the tolerability of single nucleotide backbone and sugar modifications, including deoxyribonucleic acid, 2'--(2-methoxyethyl), locked nucleic acid, unlocked nucleic acid, mismatches, butane diol substitution, and butane diol insertion. We synthesized 522 siRNA variants and evaluated their efficacy . Our findings demonstrate that individual tolerability is significantly influenced by the modification's sequence, pattern, and position, with limited universal principles identifiable from this dataset. The efficacy results are probably driven by the thermodynamic balance defined by a combination of parameters. The framework presented here will serve as a reference dataset to facilitate the expansion of chemical diversity in therapeutic siRNAs.

摘要

化学修饰的小干扰RNA(siRNA)无疑代表了一类开创性的药物。对其天然结构进行刻意的化学修饰对它们的巨大成功起到了关键作用。在某些位置进行特定修饰可增强其效力、安全性、稳定性和特异性。在临床研究中,2'-O-甲基和2'-氟是最常用的修饰。对于完全修饰的siRNA中广泛的化学变化对耐受性的影响尚未进行全面评估。在本研究中,我们在完全修饰的siRNA中使用两个序列,系统地评估单核苷酸主链和糖修饰的耐受性,包括脱氧核糖核酸、2'-O-(2-甲氧基乙基)、锁核酸、非锁核酸、错配、丁二醇取代和丁二醇插入。我们合成了522种siRNA变体并评估了它们的效力。我们的研究结果表明,个体耐受性受到修饰的序列、模式和位置的显著影响,从该数据集中可识别的通用原则有限。效力结果可能由多种参数组合定义的热力学平衡驱动。这里提出的框架将作为一个参考数据集,以促进治疗性siRNA化学多样性的扩展。

相似文献

2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Nucleic Acid Nanocapsules as a New Platform to Deliver Therapeutic Nucleic Acids for Gene Regulation.
Acc Chem Res. 2025 Jul 1;58(13):1951-1962. doi: 10.1021/acs.accounts.5c00126. Epub 2025 Jun 9.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

本文引用的文献

1
Chemistry, structure and function of approved oligonucleotide therapeutics.
Nucleic Acids Res. 2023 Apr 11;51(6):2529-2573. doi: 10.1093/nar/gkad067.
2
Recent progress in non-native nucleic acid modifications.
Chem Soc Rev. 2021 Apr 26;50(8):5126-5164. doi: 10.1039/d0cs01430c.
3
Single-Stranded Phosphorothioated Regions Enhance Cellular Uptake of Cholesterol-Conjugated siRNA but Not Silencing Efficacy.
Mol Ther Nucleic Acids. 2020 Sep 4;21:991-1005. doi: 10.1016/j.omtn.2020.07.029. Epub 2020 Jul 25.
4
Therapeutic siRNA: state of the art.
Signal Transduct Target Ther. 2020 Jun 19;5(1):101. doi: 10.1038/s41392-020-0207-x.
5
High-Throughput Analysis Reveals Rules for Target RNA Binding and Cleavage by AGO2.
Mol Cell. 2019 Aug 22;75(4):741-755.e11. doi: 10.1016/j.molcel.2019.06.012. Epub 2019 Jul 16.
6
Current Development of siRNA Bioconjugates: From Research to the Clinic.
Front Pharmacol. 2019 Apr 26;10:444. doi: 10.3389/fphar.2019.00444. eCollection 2019.
7
Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates.
Mol Ther. 2018 Mar 7;26(3):708-717. doi: 10.1016/j.ymthe.2017.12.021. Epub 2018 Jan 4.
8
Chemical Modification of the siRNA Seed Region Suppresses Off-Target Effects by Steric Hindrance to Base-Pairing with Targets.
ACS Omega. 2017 May 31;2(5):2055-2064. doi: 10.1021/acsomega.7b00291. Epub 2017 May 12.
9
Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo.
Nucleic Acids Res. 2018 Mar 16;46(5):2185-2196. doi: 10.1093/nar/gky037.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验